Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time—a population-based comparative study

Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and... Advanced-stage HL survivors treated with full-dose chemotherapy were at increased risk of work loss, not only explained by relapse, secondary malignancies, or cardiovascular disease. Implications for Cancer Survivors The results call for increased awareness and evaluation of reasons for long-term work disability following intensive chemotherapy among young HL survivors. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cancer Survivorship: Research and Practice Springer Journals

Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time—a population-based comparative study

Loading next page...
 
/lp/springer-journals/sick-leave-and-disability-pension-in-hodgkin-lymphoma-survivors-by-RqN7ACcKU3

References (38)

Publisher
Springer Journals
Copyright
Copyright © 2015 by Springer Science+Business Media New York
Subject
Medicine & Public Health; Public Health; Oncology; Health Promotion and Disease Prevention; Health Informatics; Quality of Life Research; Primary Care Medicine
ISSN
1932-2259
eISSN
1932-2267
DOI
10.1007/s11764-015-0436-0
pmid
25689964
Publisher site
See Article on Publisher Site

Abstract

Advanced-stage HL survivors treated with full-dose chemotherapy were at increased risk of work loss, not only explained by relapse, secondary malignancies, or cardiovascular disease. Implications for Cancer Survivors The results call for increased awareness and evaluation of reasons for long-term work disability following intensive chemotherapy among young HL survivors.

Journal

Journal of Cancer Survivorship: Research and PracticeSpringer Journals

Published: Feb 18, 2015

There are no references for this article.